Error: Could not add to watchlist. X

Biogen Inc

+ Watchlist
BIIB:US
NASDAQ GS
404.63
USD
0.35
0.09%
As of 20:10:00 ET on 07/07/2015.
Open
399.86
Day Range
399.51 - 412.00
Volume
1,189,697
Previous Close
404.28
52Wk Range
290.85 - 480.18
1 Yr Return
24.24%
Current P/E Ratio (TTM)
29.49
Earnings per Share (USD) (TTM)
13.72
Market Cap (b USD)
95.181
Shares Outstanding (m)
235.230
Price/Sales (TTM)
9.42
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Biogen Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.
ADDRESS
225 Binney Street
Cambridge, MA 02142
United States
PHONE
781-464-2000
  • George A Scangos
    Chief Executive Officer
  • Susan H Alexander
    Exec VP/Chief Legal Ofcr/Secy
  • Paul J Clancy
    Exec VP:Finance/CFO
  • Stephen H Holtzman "Steve"
    Exec VP:Corporate Development
  • Stuart A Kingsley "Tony"
    Exec VP:Global Commercial Ops
Show More